| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/19/2012 | US20120014954 Sparc binding scfvs |
| 01/19/2012 | US20120014953 Treating and evaluating inflammatory disorders |
| 01/19/2012 | US20120014950 Antibodies That Specifically Bind to DR3 |
| 01/19/2012 | US20120014925 Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof |
| 01/19/2012 | US20120014918 Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as dhodh inhibitors |
| 01/19/2012 | US20120014910 Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis |
| 01/19/2012 | US20120014884 Menthol-derivative compounds and use thereof as oral and systemic active agents |
| 01/19/2012 | CA2803999A1 Anti-angiogenic composition containing macrolactin a and a derivative thereof as active ingredients |
| 01/18/2012 | EP2407476A1 Steroid compound |
| 01/18/2012 | EP2407473A2 Method for producing phosphorus-containing compounds |
| 01/18/2012 | EP2407467A1 Crystalline compound of1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol and lactic acid |
| 01/18/2012 | EP2407466A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/18/2012 | EP2406266A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| 01/18/2012 | EP2406255A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases |
| 01/18/2012 | EP2406222A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 01/18/2012 | EP2406221A2 Sodium salt of 5-cyclopropyl-2-{ý2-(2,6- difluorophenyl)pyrimidin-5-yl¨amino}benzoic acid as dhodh inhibitor |
| 01/18/2012 | EP2327413A9 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use |
| 01/18/2012 | EP2300485B1 Pyrrolo-[2, 3-c]-pyridine derivatives as p38 kinase inhibiting agents |
| 01/18/2012 | EP1808446B1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/18/2012 | EP1784173B1 Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyacrylate derivatives |
| 01/18/2012 | EP1546138B1 Raloxifene l-lactate or a hemihydrate thereof, their uses, pharmaceutical compositions and preparation processes |
| 01/18/2012 | EP1494730B1 Composition for hard tissue augmentation |
| 01/18/2012 | CN102325796A Anti-human [alpha]9 integrin antibody and use thereof |
| 01/18/2012 | CN102325768A Compounds and methods for the treatment of pain and other diseases |
| 01/18/2012 | CN102325754A Cyclic compound having hetero atom |
| 01/18/2012 | CN102325535A Extraits de cajanus et glucosamine pour troubles inflammatoires |
| 01/18/2012 | CN102321626A Means for inhibiting the expression of protein kinase 3 |
| 01/18/2012 | CN102319438A Genistein clathrate compound-containing preparation and its preparation method and use |
| 01/18/2012 | CN102319375A Medicine for treating cervical spondylopathy and preparation method thereof |
| 01/18/2012 | CN102319364A Manufacturing method of dendrobium candidum wallex lindll pure powder tablets |
| 01/18/2012 | CN102319339A Chinese medicinal composition for treating senile fracture |
| 01/18/2012 | CN102319335A Propolis comprehensive plaster |
| 01/18/2012 | CN102319332A Musk bone reunion Chinese medicinal composition |
| 01/18/2012 | CN102319330A Traditional Chinese medicine cataplasma for treating hyperosteogeny and preparation method thereof |
| 01/18/2012 | CN102319320A Medicament for treating osteopathy |
| 01/18/2012 | CN102319316A Rapid bone hyperplasia healing agent |
| 01/18/2012 | CN102319303A Chinese medicinal composition for treating osteoarthritis |
| 01/18/2012 | CN102319266A krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 01/18/2012 | CN102319240A Application of deacetylmycoepoxydiene serving as Hsp90 inhibitor |
| 01/18/2012 | CN102319206A Stable aqueous solution of recombinant human interleukin-11, and preparation method thereof |
| 01/18/2012 | CN102048787B Traditional Chinese medicine preparation for treating degenerative joint disease and preparation method thereof |
| 01/18/2012 | CN101721495B Chinese herbal medicine wine for treating rheumatoid arthritis |
| 01/18/2012 | CN101590208B Medicament composition for treating rheumatoid arthritis, and preparation method thereof |
| 01/18/2012 | CN101524493B Multifunctional Chinese medicine honeyed pill |
| 01/18/2012 | CN101406466B Cinnamic acid transdermal patch and preparation technique thereof |
| 01/18/2012 | CN101322755B Medicament composition, external-use paste and preparation thereof |
| 01/17/2012 | US8097589 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 01/17/2012 | US8097585 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
| 01/17/2012 | US8096419 Compound |
| 01/17/2012 | CA2517390C Chroman-derived anti-androgens for treatment of androgen-mediated disorders |
| 01/17/2012 | CA2514152C Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
| 01/17/2012 | CA2485852C Agent for binding a plurality of c-reactive protein and their use in the treatment and prevention of tissue damage |
| 01/17/2012 | CA2484269C Compounds and method for coating surfaces in a haemocompatible manner |
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/12/2012 | WO2012005229A1 N-hydroxyformamide derivative and pharmaceutical containing same |
| 01/12/2012 | WO2012005227A1 Tetrahydrocarboline derivative |
| 01/12/2012 | WO2012004287A1 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
| 01/12/2012 | WO2012003810A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |
| 01/12/2012 | WO2012003544A1 Protein kinase inhibitors and methods of treatment |
| 01/12/2012 | WO2011108882A3 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
| 01/12/2012 | WO2011099832A3 Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same |
| 01/12/2012 | US20120010599 Inorganically surface-modified polymers and methods for making and using them |
| 01/12/2012 | US20120010295 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/12/2012 | US20120010287 N, n -dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same |
| 01/12/2012 | US20120010282 Tautomycetin and Tautomycetin Analog Biosynthesis |
| 01/12/2012 | US20120010265 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 01/12/2012 | US20120010261 Choline and tromethamine salt of licofelone |
| 01/12/2012 | US20120010256 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2012 | US20120010214 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES |
| 01/12/2012 | US20120010206 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/12/2012 | US20120010191 Pyridone and aza-pyridone compounds and methods of use |
| 01/12/2012 | US20120010188 Imidazopyridine Compounds |
| 01/12/2012 | US20120010185 New pyridone derivates with mch antagonistic activity and medicaments comprising these compounds |
| 01/12/2012 | US20120010181 Compounds for the treatment of inflammatory disorders |
| 01/12/2012 | US20120010159 Combination therapies with cox-2 inhibitors and treprostinil |
| 01/12/2012 | US20120010158 Tumor necrosis factor inhibiting peptides and uses thereof |
| 01/12/2012 | US20120010156 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 01/12/2012 | US20120010139 Thermal responsive composition for treating bone diseases |
| 01/12/2012 | US20120010136 Use of cd31 peptides in the treatment of thrombotic and autoimmune disorders |
| 01/12/2012 | US20120010135 Spiro derivatives for the modulation of stearoyl-coa desaturase |
| 01/12/2012 | US20120009648 DNA polymerase lambda and uses thereof |
| 01/12/2012 | US20120009288 Use of acacia extracts and their compounds on inhibition of xanthine oxidase |
| 01/12/2012 | US20120009270 Treatment methods using a particulate cartilage system |
| 01/12/2012 | US20120009268 Modified Virus Vectors and Methods of Making and Using the Same |
| 01/12/2012 | US20120009230 Malleable implants containing demineralized bone matrix |
| 01/12/2012 | US20120009226 Highly pure laquinimod or a pharmaceutically acceptable salt thereof |
| 01/12/2012 | US20120009224 Particulate cartilage treatment composition |
| 01/12/2012 | US20120009195 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 01/12/2012 | US20120009191 Methods of treating bone-loss disorders using a gm-csf antagonist |
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009184 Anti-C5 Alpha Antibodies |
| 01/12/2012 | US20120009141 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 01/12/2012 | DE102010026500A1 Verfahren zur Herstellung von autologen Proteinen Process for the preparation of autologous proteins |
| 01/12/2012 | CA2804918A1 N-hydroxyformamide derivative and medicament containing same |
| 01/12/2012 | CA2804648A1 Protein kinase inhibitors and methods of treatment |
| 01/12/2012 | CA2804473A1 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
| 01/12/2012 | CA2802216A1 Tetrahydrocarboline derivative |
| 01/11/2012 | EP2404935A1 Immunoglobulin binding HOSM |
| 01/11/2012 | EP2404918A1 Pyridine derivative |
| 01/11/2012 | EP2404910A2 Polymorphs of 2-(3-cyano-4-Isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same |